GlassScriptPhysician profile
Kristopher P Jerry
NPI 1063861979
$20,937.77
in general payments reported to CMS, 2019-2025
36 companies · $1,093 in 2025
The $1,093 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,988 · 2020: $973 · 2021: $2,432 · 2022: $3,473 · 2023: $2,561 · 2024: $5,417 · 2025: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,200 · Food and Beverage: $2,484 · Travel and Lodging: $2,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,200.00 |
| Food and Beverage | $2,483.88 |
| Travel and Lodging | $2,388.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $4,200.00 | 2024 | |
| Arthrex, INC. | $4,156.00 | 2019 | |
| Treace Medical Concepts, INC. | $2,691.37 | 2022-2025 | |
| Stryker Corporation | $1,481.23 | 2021-2025 | Augment Injectable, Hoffmann, Citrefix |
| Triad Life Sciences INC. | $1,338.21 | 2022 | |
| In2bones USA, LLC | $1,298.80 | 2022 | |
| Paragon 28, INC. | $1,202.88 | 2021 | |
| Trimed, INC. | $685.92 | 2021 | |
| Southern Edge Orthopaedics, INC. | $685.16 | 2020 | |
| Medartis INC. | $508.96 | 2019 | |
| International Life Sciences | $488.03 | 2023-2024 | Flexband |
| Kerecis Limited | $339.43 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $225.40 | 2021-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Organogenesis INC. | $179.37 | 2019-2022 | |
| Reprise Biomedical, INC. | $175.48 | 2024 | Miro3d |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $164.68 | 2020 | |
| Medshape, INC. | $147.53 | 2025 | Dynanail |
| Horizon Therapeutics Plc | $141.82 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $137.01 | 2023-2025 | Nuzyra |
| Grt US Holding, INC. | $95.73 | 2022 | |
| Nevro Corp. | $94.50 | 2022-2023 | Senza |
| Wright Medical Technology, INC. | $94.25 | 2020 | |
| Bard Peripheral Vascular, INC. | $92.97 | 2023 | Venclose Maven Catheter |
| Crossroads Extremity Systems, LLC | $53.75 | 2021 | |
| Ermi LLC | $37.52 | 2023 | |
| Bioventus LLC | $36.71 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Biotissue Holdings INC. | $32.30 | 2021 | |
| Abbott Laboratories | $21.36 | 2024 | Proclaim |
| Medtronic, INC. | $19.46 | 2022 | |
| Fidia Pharma USA INC. | $18.75 | 2019 | |
| Mimedx Group, INC. | $18.09 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $17.80 | 2023 | Seglentis |
| Alfasigma USA, INC. | $15.56 | 2021 | |
| Djo, LLC | $15.31 | 2025 | Cmf |
| Kci USA, INC. | $14.71 | 2022 | |
| Nabriva Therapeutics, Plc | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Jerry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.